id: ciwa_ar_protocol_adaptation_to_safe_ghb_withdrawal_management
name: Adaptation of CIWA-Ar Protocol for GHB Withdrawal â†’ Successful Management of
  GHB Withdrawal Delirium
from_node:
  node_id: ciwa_ar_protocol_adaptation
  node_name: Adaptation of CIWA-Ar Protocol for GHB Withdrawal
to_node:
  node_id: safe_ghb_withdrawal_management
  node_name: Successful Management of GHB Withdrawal Delirium
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: CIWA-Ar scale (validated for alcohol withdrawal) is adapted to assess GHB
  withdrawal severity'
- 'Step 2: Standardized scoring provides objective guidance for symptom-triggered
  benzodiazepine dosing'
- 'Step 3: Fixed and symptom-triggered benzodiazepine regimen based on CIWA-Ar scores
  enables responsive treatment titration'
- 'Step 4: Systematic assessment and dosing protocol results in successful management
  of severe GHB withdrawal delirium'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Po-Chiao Liao et al. 2018. "Clinical management of gamma-hydroxybutyrate
    (GHB) withdrawal delirium with CIWA-Ar protocol.." *Journal of the Formosan Medical
    Association = Taiwan yi zhi*. https://doi.org/10.1016/j.jfma.2018.06.005
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.775250'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: clinician_training_standardized_protocols
  direction: strengthens
  strength: strong
  description: Clinician familiarity with CIWA-Ar from alcohol withdrawal management
    facilitates adaptation to GHB withdrawal
- name: severity_of_withdrawal
  direction: strengthens
  strength: moderate
  description: Protocol may be particularly valuable in severe cases (delirium, hallucinations)
    where objective assessment is most critical
